Endocannabinoids and Lipid Mediators in Brain Functions
The science of cannabinoids is 50 years old. These past years provided a remarkable and constant number of breakthroughs, showing that the signaling mediated by endocannabinoids and lipid mediators impacts almost every function of the body. Indeed, this represents a special field of research, which...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
| Edition: | 1st ed. 2017. |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-319-57371-7 |
Table of Contents:
- - The Endocannabinoid System in Leptin-Driven Changes of Orexinergic Signalling Under Physiological and Pathological Conditions
- How CB1 Receptor Activity and Distribution Contribute to Make the Male and Female Brain Different Towards Cannabinoid-Induced Effects
- Endocannabinoids, Stress, and Negative Affect
- Cell-Autonomous Endocannabinoid Production Shapes Polarized and Dynamic Distribution and Signaling Patterns of Cannabinoid CB1 Receptors in Neurons
- Endocannabinoid-Dependent Synaptic Plasticity in Striatum
- Lipid Mediators in the Regulation of Emotions, Memory and Cognitive Functions
- The Endocannabinoid System in Prefrontal Synaptopathies
- Cannabinoids and Mitochondria
- Endocannabinoids and Lipid Mediators in Brain Function
- Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology
- Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases
- Mast Cells and Glia as Targets for the Anandamide Congener Palmitoylethanolamide, and Anti-Inflammatory and Neuroprotective Lipid-Signaling Molecule.